O

Obio Technology Shanghai Corp Ltd
SSE:688238

Watchlist Manager
Obio Technology Shanghai Corp Ltd
SSE:688238
Watchlist
Price: 5.29 CNY -3.11% Market Closed
Market Cap: 3.4B CNY
Have any thoughts about
Obio Technology Shanghai Corp Ltd?
Write Note

Obio Technology Shanghai Corp Ltd
Investor Relations

Obio Technology Shanghai Corp. Ltd. engages in biomedical basic research, gene therapy drug incubation, and clinical grade gene therapy virus vector CDMO service provision. The company is headquartered in Shanghai, Shanghai and currently employs 631 full-time employees. The company went IPO on 2022-03-22. The firm is mainly engaged in providing contract research organization (CRO) services such as gene therapy vector development and gene function research for the basic research of gene therapy, as well as contract research and development production organization (CDMO) services such as pharmaceutical research and clinical sample production for the research and development of gene drugs. The firm mainly conducts business in the European and American markets and the domestic market.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Oudong Pan
Founder & Chairman of the Board
No Bio Available
Mr. Guodong Jia Ph.D.
GM & Director
No Bio Available
Ms. Luyuan Xu
Deputy GM, CFO & Board Secretary
No Bio Available
Mr. Junyi Pan
Investment Director & Director
No Bio Available
Mr. Fujie Wang
VP of Supply Chain & Information Technology and Director
No Bio Available
Ms. Shan Yin
Deputy GM & Director
No Bio Available
Ms. Qingmei Xia
Deputy General Manager
No Bio Available
Mr. Xinglin Yang
R & D Director
No Bio Available
Qinbin Wu
Chief Quality Officer
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
Block 19, Lane 908, Ziping Rd, International Medical Park, Pudong New District
Contacts
+864001515198
www.obiosh.com